Skip to main content
Delfa

← All assets

Venlafaxine

4 trials in this asset. Source: ClinicalTrials.gov, as of July 21, 2026.

Trials

4

Ongoing

0

Recruiting

0

Completed

3

Sites

5

Countries

2

Endpoints

27

Composite endpoints

0

Distinct sites and countries across this asset's trials. A site running several of its trials counts once, matching the map. All 27 linked ClinicalTrials.gov endpoints are classified into the categories below. Trial and endpoint linkage does not by itself establish treatment attribution for every endpoint.

Development

Where the program stands

Trials by phase

Phase 1
1
Phase 4
1
Not applicable
2

Trials by status

Completed
3
Terminated
1

Evidence coverage

What this asset has been measured on

Endpoints grouped into outcome categories, ranked by how often they are measured across this asset's trials.

Other (unclassified)
8
Behavior / neuropsychiatric
7
Other clinical outcomes
4
Global cognition
3
Function / daily living
2
Memory
1
Disease progression
1
Fluid / digital biomarkers
1

Most-measured metrics

Top 20 metrics across this asset's endpoints

Normalized metric codes are available for 1 of 27 classified ClinicalTrials.gov endpoints for this asset; the ranking below covers that coded subset.

Mini-Mental State Examination (MMSE)Cognition

1

Trials

Trials for this asset

Every trial for this asset, with the same search, filters, and sort as the Trials tab.

4 of 4

Alzheimer’s disease and related dementias trials
Asset / Disease areaKey I/E criterionEvidence
DIADs-3Venlafaxine for Depression in Alzheimer's Disease (DIADs-3)

Venlafaxine

Alzheimer’s disease

Alzheimer's diseaseNot applicableCompleted2Dec 2016-results
NCT03274817A Proof of Concept Study of the Prevention of Mild Cognitive Impairment and Eventual Alzheimer's Disease Using F18 Flutemetamol

Escitalopram, Venlafaxine

Alzheimer’s disease, MCI / preclinical Alzheimer’s

Study partner/caregiver requiredPh 1Terminated1Sep 2019-
CCICAMH - McMaster Collaborative Care Initiative For Mental Health Risk Factors In Dementia

Sertraline, Venlafaxine

Mixed / unspecified dementia

Age 60-65Not applicableCompleted1Jul 20201
NCT00177671Antidepressant Medication Plus Donepezil for Treating Late-life Depression

Donepezil, Duloxetine, Escitalopram, Venlafaxine

Mixed / unspecified dementia

Age ≥65Ph 4Completed1Sep 20095results

Showing 1-4 of 4 trials